Biomarker for Friedreich's Ataxia (BioFridA)

Clinical trial NCT04548921 · UNKNOWN

Trial details

NCT number: NCT04548921
Sponsor: CENTOGENE GmbH Rostock
Status: UNKNOWN
Study type: OBSERVATIONAL

FXN Gene FRDA Hereditary Diseases

Start date: 2020-07-01
Primary completion: 2023-12-31
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.